ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Abudureyimu Tuerhong
Matched on OpenAlex author ID A5002445102. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper
Papers 3
- CPT1B maintains redox homeostasis and inhibits ferroptosis to induce gemcitabine resistance via the KEAP1/NRF2 axis in pancreatic cancer. Co-author DOI 10.1016/j.surg.2023.12.019↗
- Mechanical Regulation of Redox Balance via the Induction of the PIN1/NRF2/ARE Axis in Pancreatic Cancer. Co-author DOI 10.3390/ijms24043476↗
- Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00018-021-03866-y↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Qingcai Meng · 3 shared papers, 2021–2024 · strength 0.50
- Paper CPT1B maintains redox homeostasis and inhibits ferroptosis to induce gemcitabine resistance via the KEAP1/NRF2 axis in … DOI 10.1016/j.surg.2023.12.019↗
- Paper Mechanical Regulation of Redox Balance via the Induction of the PIN1/NRF2/ARE Axis in Pancreatic Cancer. DOI 10.3390/ijms24043476↗
- Paper Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma. DOI 10.1007/s00018-021-03866-y↗
- Jie Hua · 3 shared papers, 2021–2024 · strength 0.50
- Paper CPT1B maintains redox homeostasis and inhibits ferroptosis to induce gemcitabine resistance via the KEAP1/NRF2 axis in … DOI 10.1016/j.surg.2023.12.019↗
- Paper Mechanical Regulation of Redox Balance via the Induction of the PIN1/NRF2/ARE Axis in Pancreatic Cancer. DOI 10.3390/ijms24043476↗
- Paper Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma. DOI 10.1007/s00018-021-03866-y↗
- Jin Xu · 3 shared papers, 2021–2024 · strength 0.50
- Paper CPT1B maintains redox homeostasis and inhibits ferroptosis to induce gemcitabine resistance via the KEAP1/NRF2 axis in … DOI 10.1016/j.surg.2023.12.019↗
- Paper Mechanical Regulation of Redox Balance via the Induction of the PIN1/NRF2/ARE Axis in Pancreatic Cancer. DOI 10.3390/ijms24043476↗
- Paper Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma. DOI 10.1007/s00018-021-03866-y↗
- Chen Liang · 3 shared papers, 2021–2024 · strength 0.50
- Paper CPT1B maintains redox homeostasis and inhibits ferroptosis to induce gemcitabine resistance via the KEAP1/NRF2 axis in … DOI 10.1016/j.surg.2023.12.019↗
- Paper Mechanical Regulation of Redox Balance via the Induction of the PIN1/NRF2/ARE Axis in Pancreatic Cancer. DOI 10.3390/ijms24043476↗
- Paper Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma. DOI 10.1007/s00018-021-03866-y↗
- Xianjun Yu · 3 shared papers, 2021–2024 · strength 0.50
- Paper CPT1B maintains redox homeostasis and inhibits ferroptosis to induce gemcitabine resistance via the KEAP1/NRF2 axis in … DOI 10.1016/j.surg.2023.12.019↗
- Paper Mechanical Regulation of Redox Balance via the Induction of the PIN1/NRF2/ARE Axis in Pancreatic Cancer. DOI 10.3390/ijms24043476↗
- Paper Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma. DOI 10.1007/s00018-021-03866-y↗
- Si Shi · 3 shared papers, 2021–2024 · strength 0.50
- Paper CPT1B maintains redox homeostasis and inhibits ferroptosis to induce gemcitabine resistance via the KEAP1/NRF2 axis in … DOI 10.1016/j.surg.2023.12.019↗
- Paper Mechanical Regulation of Redox Balance via the Induction of the PIN1/NRF2/ARE Axis in Pancreatic Cancer. DOI 10.3390/ijms24043476↗
- Paper Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma. DOI 10.1007/s00018-021-03866-y↗
- Wei Wang · 2 shared papers, 2021–2023 · strength 0.30
- Bo Zhang · 1 shared paper, 2024 · strength 0.21
- Zeyin Rong · 1 shared paper, 2023 · strength 0.17
- Zhen Tan · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.